Latest news
Loading news…
Esperion
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Ann Arbor, Michigan, United States Founded 1998 251-500 employees For Profit
Esperion develops and commercializes pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Esperion on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Esperion was acquired by Essence Parent Inc. in 2026.
Total Funding
$1.17B
Funding Rounds
11
Last Funding
Acquisitions
1
Monthly Visits
Contacts
315
Ticker
ESPR
NASDAQ
Patents
30
16 trademarks
About Esperion
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ESPR
- Exchange
- NASDAQ
- IPO date
- Jun 26, 2013
- Raised at IPO
- $70M
- Valuation at IPO
- $196M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 40
- Active products
- 23
- Patents granted
- 30
- Trademarks
- 16
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $6.59M
Company Info
- Founded
- 1998
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 317
- HQ
- Ann Arbor, Michigan, United States
- Region
- Great Lakes, Midwestern US
- Exit date
- Jun 26, 2013
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 3.8
- Trend (30d)
- -1.4
- Trend (90d)
- -0.9
- Last leadership hire
- Dec 4, 2025
- Last layoff mention
- Oct 18, 2021
Esperion Funding Rounds
11 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 11Show
Page 1 / 3
Esperion Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Corstasis Therapeutics | $75M | 2026-03-03 | Esperion | Health CareHome Health CareOutpatient CareTherapeutics | United States |
1–1 of 1Show
Page 1 / 1
Esperion Key People
President and CEO
Head of Investor Relations
Sr. VP & Director
Chief Commercial Officer
VICE PRESIDENT, STRATEGIC MARKETING & PRODUCT PLANNING
315
professional contacts at Esperion
Contact execs at Esperion →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Esperion
Loading news…
FAQs about Esperion
People who checked this page also checked these
Sectors Esperion invests & acquires in
Browse the full Acquirezy directory.